Metabotropic glutamate receptor 3
Metabotropic Glutamate Receptor 3[edit | edit source]
Metabotropic glutamate receptor 3 (mGlu3) is a type of G protein-coupled receptor (GPCR) that is activated by the neurotransmitter glutamate. It is one of the eight metabotropic glutamate receptors, which are divided into three groups based on their sequence homology, signal transduction mechanisms, and pharmacological properties.
Structure[edit | edit source]
Metabotropic glutamate receptor 3 is a member of the Class C GPCR family. Like other members of this family, mGlu3 has a large extracellular domain that binds glutamate, a seven-transmembrane domain that spans the cell membrane, and an intracellular domain that interacts with G proteins. The receptor is typically found as a dimer, which is important for its function.
Function[edit | edit source]
mGlu3 receptors are primarily involved in modulating synaptic transmission and neuronal excitability. They are predominantly expressed in the central nervous system, including the cerebral cortex, hippocampus, and thalamus. Activation of mGlu3 receptors can lead to the inhibition of adenylyl cyclase, resulting in decreased levels of cyclic AMP (cAMP) and modulation of various downstream signaling pathways.
Pharmacology[edit | edit source]
The pharmacological modulation of mGlu3 receptors has been of significant interest due to their potential therapeutic applications. Selective agonists and antagonists have been developed to study the receptor's function and its role in various neurological disorders. ML337 is a selective positive allosteric modulator of mGlu3, which has been used in research to explore the receptor's potential as a drug target.
Clinical Significance[edit | edit source]
mGlu3 receptors have been implicated in several neurological and psychiatric disorders, including schizophrenia, anxiety, and depression. Modulation of mGlu3 receptor activity is being investigated as a potential therapeutic strategy for these conditions. The receptor's role in neuroprotection and neuroinflammation also makes it a target of interest in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD